Physiological Changes in Cardiovascular System During Pregnancy

During pregnancy, the cardiovascular system undergoes significant changes to accommodate the growing fetus. These changes include a drop in diastolic blood pressure by 10 mmHg during the second trimester, circulating blood volume increases by approximately 50%, leading to a dilutional ‘physiological anaemia’ and cardiac output increases most sharply throughout the first trimester.

During pregnancy, heart rate progressively increases until reaching a peak in the third trimester. The overall change in heart rate represents approximately a 20–25% increase from baseline. However, a grade 2/6 diastolic murmur at the mitral area and pulsus alternans are not typical findings in a healthy pregnancy. It is important for healthcare providers to be aware of these physiological changes to properly monitor and manage the health of pregnant individuals.

When differentiating between spider naevi and telangiectasia, it is important to note that spider naevi fill from the centre when pressed, while telangiectasia fill from the edge. A woman presenting with a small lesion surrounded by tiny blood vessels radiating from the middle that refills from the centre is likely to have a spider naevus. This condition is commonly associated with liver failure, making it the most likely diagnosis.

Understanding Spider Naevi

Spider naevi, also known as spider angiomas, are characterized by a central red papule surrounded by capillaries. These lesions can be identified by their ability to blanch upon pressure. Spider naevi are typically found on the upper part of the body and are more common in childhood, affecting around 10-15% of people.

To differentiate spider naevi from telangiectasia, one can press on the lesion and observe how it fills. Spider naevi fill from the center, while telangiectasia fills from the edge. It is important to note that spider naevi may be associated with liver disease, pregnancy, and the use of combined oral contraceptive pills.

In summary, understanding spider naevi is important for proper diagnosis and management. By recognizing their distinct characteristics and potential associations, healthcare professionals can provide appropriate care for their patients.

Understanding Discitis: Causes, Symptoms, Diagnosis, and Treatment

Discitis is a condition characterized by an infection in the intervertebral disc space, which can lead to serious complications such as sepsis or an epidural abscess. The most common cause of discitis is bacterial, with Staphylococcus aureus being the most frequent culprit. However, it can also be caused by viral or aseptic factors. The symptoms of discitis include back pain, pyrexia, rigors, and sepsis. In some cases, neurological features such as changing lower limb neurology may occur if an epidural abscess develops.

To diagnose discitis, imaging tests such as MRI are used due to their high sensitivity. A CT-guided biopsy may also be required to guide antimicrobial treatment. The standard therapy for discitis involves six to eight weeks of intravenous antibiotic therapy. The choice of antibiotic depends on various factors, with the most important being the identification of the organism through a positive culture, such as a blood culture or CT-guided biopsy.

Complications of discitis include sepsis and epidural abscess. Therefore, it is essential to assess the patient for endocarditis, which can be done through transthoracic echo or transesophageal echo. Discitis is usually due to haematogenous seeding of the vertebrae, which implies that the patient has had a bacteraemia, and seeding could have occurred elsewhere. Understanding the causes, symptoms, diagnosis, and treatment of discitis is crucial in managing this condition and preventing its complications.

Common Knee Problems in Children and Young Adults

Knee problems are common in children and young adults, especially those who are active in sports.
Chondromalacia patellae is a condition that is more common in teenage girls. It is characterized by the softening of the cartilage of the patella, which can cause anterior knee pain when walking up and down stairs or rising from prolonged sitting. This condition usually responds well to physiotherapy.

Osgood-Schlatter disease, also known as tibial apophysitis, is often seen in sporty teenagers. It causes pain, tenderness, and swelling over the tibial tubercle.

Osteochondritis dissecans can cause pain after exercise, as well as intermittent swelling and locking of the knee.

Patellar subluxation can cause medial knee pain due to lateral subluxation of the patella. The knee may also give way.

Patellar tendonitis is more common in athletic teenage boys. It causes chronic anterior knee pain that worsens after running. On examination, the area below the patella is tender. It is important to note that referred pain may come from hip problems such as slipped upper femoral epiphysis.

Telogen effluvium is characterized by hair loss and thinning as a result of experiencing significant stress. In this case, the patient’s recent physical stress from giving birth is a likely cause of her hair becoming thinner due to telogen effluvium. The hair loss patterns observed do not match those of alopecia areata or alopecia totalis, which respectively cause distinct areas of complete hair loss or complete loss of all hair on the head and face.

Input:
Alopecia may be divided into scarring (destruction of hair follicle) and non-scarring (preservation of hair follicle). Scarring alopecia can be caused by trauma, burns, radiotherapy, lichen planus, discoid lupus, and untreated tinea capitis. Non-scarring alopecia can be caused by male-pattern baldness, drugs such as cytotoxic drugs, carbimazole, heparin, oral contraceptive pill, and colchicine, nutritional deficiencies such as iron and zinc deficiency, autoimmune conditions such as alopecia areata, telogen effluvium, hair loss following a stressful period such as surgery, and trichotillomania.

Output:
– Alopecia can be categorized into scarring and non-scarring types.
– Scarring alopecia is caused by trauma, burns, radiotherapy, lichen planus, discoid lupus, and untreated tinea capitis.
– Non-scarring alopecia is caused by male-pattern baldness, drugs such as cytotoxic drugs, carbimazole, heparin, oral contraceptive pill, and colchicine, nutritional deficiencies such as iron and zinc deficiency, autoimmune conditions such as alopecia areata, telogen effluvium, hair loss following a stressful period such as surgery, and trichotillomania.

The majority of croup cases are caused by parainfluenza virus, and it is recommended to avoid throat examination as it may lead to airway obstruction.

Understanding Croup: A Respiratory Infection in Infants and Toddlers

Croup is a type of upper respiratory tract infection that commonly affects infants and toddlers. It is characterized by a barking cough, fever, and coryzal symptoms, and is caused by a combination of laryngeal oedema and secretions. Parainfluenza viruses are the most common cause of croup. The condition typically peaks between 6 months and 3 years of age, and is more prevalent during the autumn season.

The severity of croup can be graded based on the presence of symptoms such as stridor, cough, and respiratory distress. Mild cases may only have occasional barking cough and no audible stridor at rest, while severe cases may have frequent barking cough, prominent inspiratory stridor at rest, and marked sternal wall retractions. Children with moderate or severe croup, those under 6 months of age, or those with known upper airway abnormalities should be admitted to the hospital.

Diagnosis of croup is usually made based on clinical presentation, but a chest x-ray may show subglottic narrowing, commonly referred to as the steeple sign. Treatment for croup typically involves a single dose of oral dexamethasone or prednisolone, regardless of severity. In emergency situations, high-flow oxygen and nebulized adrenaline may be necessary.

Understanding croup is important for parents and healthcare providers alike, as prompt recognition and treatment can help prevent complications and improve outcomes for affected children.

If a woman over the age of 30 presents with an unexplained breast lump, it is important to refer her urgently to the breast team using a suspected cancer pathway referral. It is important to inform the patient that they are being referred to a cancer service, but also explain that not all referrals to cancer services result in a cancer diagnosis. It is incorrect to perform a biopsy as an initial investigation, as this will be done in secondary care. While fibroadenoma is a common cause of breast lumps in young women, urgent referral to the breast team is necessary to rule out cancer in patients over 30 years old. It is not appropriate to schedule a GP review in 2 weeks, as this lump needs prompt investigation by the breast team.

In 2015, NICE released guidelines for referring individuals suspected of having breast cancer. If a person is 30 years or older and has an unexplained breast lump with or without pain, or if they are 50 years or older and have discharge, retraction, or other concerning changes in one nipple only, they should be referred using a suspected cancer pathway referral for an appointment within two weeks. If a person has skin changes that suggest breast cancer or is 30 years or older with an unexplained lump in the axilla, a suspected cancer pathway referral should also be considered. For individuals under 30 years old with an unexplained breast lump with or without pain, non-urgent referral should be considered.

Guidelines for Emergency Oxygen Therapy

The British Thoracic Society has updated its guidelines for emergency oxygen therapy in 2017. The guidelines recommend that in critically ill patients, such as those experiencing anaphylaxis or shock, oxygen should be administered via a reservoir mask at 15 l/min. However, certain conditions, such as stable myocardial infarction, are excluded from this recommendation.

The guidelines also provide specific oxygen saturation targets for different patient groups. Acutely ill patients should aim for a saturation range of 94-98%, while patients at risk of hypercapnia, such as those with COPD, should aim for a lower range of 88-92%. Oxygen therapy should be reduced in stable patients with satisfactory oxygen saturation.

For COPD patients, a 28% Venturi mask at 4 l/min should be used prior to availability of blood gases. The target oxygen saturation range for these patients should be 88-92% if they have risk factors for hypercapnia but no prior history of respiratory acidosis. If the pCO2 is normal, the target range can be adjusted to 94-98%.

The guidelines also highlight situations where oxygen therapy should not be used routinely if there is no evidence of hypoxia. These include myocardial infarction and acute coronary syndromes, stroke, obstetric emergencies, and anxiety-related hyperventilation.

Overall, these guidelines provide clear recommendations for the administration of emergency oxygen therapy in different patient groups and situations.

When a woman expresses interest in starting hormone replacement therapy (HRT), it is important to gather a detailed medical history to determine her menopausal status. This includes information about her last menstrual period (LMP) and any bleeding patterns leading up to it. Based on this information, it appears that the woman in question is peri-menopausal, as she has not been without a period for a full year.

The primary reason for starting HRT is to alleviate vasomotor symptoms, such as hot flashes. However, it may also be used to prevent osteoporosis in women who have been diagnosed with premature menopause.

For women who still have a uterus, HRT should consist of a combination of estrogen and progesterone. The progesterone is essential for reducing the risk of endometrial cancer, which can occur when estrogen is used alone. Women who have had a hysterectomy will typically receive continuous estrogen-only therapy.

The type of HRT prescribed will depend on the woman’s menopausal status. Those who have had their LMP within the past year should receive cyclical combined HRT, while those who have been without a period for at least a year or who have experienced premature menopause should receive continuous combined HRT.

For women who are unable or unwilling to take HRT, there are several non-hormonal treatments available for vasomotor symptoms. These include certain selective serotonin and noradrenaline reuptake inhibitors, clonidine, and gabapentin. However, sertraline is not effective for treating hot flashes. It is worth noting that the National Institute for Health and Clinical Excellence (NICE) does not recommend the use of herbal or complementary therapies for managing hot flashes and night sweats.

Hormone replacement therapy (HRT) involves a small dose of oestrogen and progestogen to alleviate menopausal symptoms. The indications for HRT have changed due to the long-term risks, and it is primarily used for vasomotor symptoms and preventing osteoporosis in younger women. HRT consists of natural oestrogens and synthetic progestogens, and can be taken orally or transdermally. Transdermal is preferred for women at risk of venous thromboembolism.

Management of Atrial Flutter: Medications and Procedures

Atrial flutter is a type of arrhythmia that can be managed through various medications and procedures. The first step in treatment is to control the ventricular rate, which can be achieved through the administration of beta-blockers or rate-limiting calcium-channel blockers. For patients with diabetes mellitus, cardio-selective beta-blockers such as atenolol, bisoprolol, metoprolol, and nebivolol are preferred.

Amiodarone is not the first-line treatment for atrial flutter and is mainly used for ventricular tachycardias and chemical cardioversion in atrial fibrillation. Propranolol can be used for rate control, but cardio-selective beta-blockers are preferred for patients with diabetes mellitus.

Synchronised direct-current (DC) cardioversion is the first-line treatment for patients with haemodynamic instability caused by a tachyarrhythmia. However, if the patient exhibits no adverse signs, DC cardioversion is not indicated. Unsynchronised DC cardioversion is only given in cases of ventricular fibrillation.

All patients should be assessed for their risk of stroke and the need for thromboprophylaxis, with the choice of anticoagulant based on scoring criteria such as CHA2DS2-VASc. Overall, the management of atrial flutter involves a tailored approach based on the individual patient’s needs and medical history.